PDCD1 and head and neck squamous cell carcinoma: It has been shown that DCs in the regional DLNs and tumors of HNSCC are critical for PD-1/PD-L1 inhibitors, and increasing the infiltration of intratumoral DCs significantly improves the response rate to PD-1/PD-L1 inhibitors.